Use of reaction products of reducing sugars and serotonin or serotonin precursors for the treatment of cerebral disorders

摘要

The present invention relates to the use of products of the reaction of one or more reducing sugars and serotonin and/or serotonin precursors such as L-tryptophan or 5-hydroxy-L-tryptophan under the conditions of the Maillard reaction and subsequent Amadori or Heyns rearrangement for the treatment of cerebral disorders, especially insomnia and depressions.